Saturday 17 October 2026
Export PLSE’s income statement to Excel — free account
Pulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022. In the quarter to June 2026, revenue grew 4,922.2%, EPS fell 28.6% and free cash flow fell 45.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
44.27
1.32
−2.90%
Follow PLSE
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 |
Altman Z-Score |
— | — | — | — | — | 4.11 | (6.18) | — | — | 31.41 |
P/S ratio |
— | — | — | — | — | 0.00 | 60.44 | — | — | 1,526.95 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | (16.58) | (12.64) | — | — | (10.11) |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 |
P/Operating CF |
— | — | — | — | — | (32.63) | (11.72) | — | — | (62.71) |
P/B ratio |
— | — | — | — | — | 11.60 | 0.00 | — | — | 11.47 |
Price to Tangible BV |
— | — | — | — | — | 13.95 | 0.00 | — | — | 11.97 |
EV/Sales |
— | — | — | — | — | 0.00 | 63.54 | — | — | 1,502.31 |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 |
EV/Operating CF |
— | — | — | — | — | (7.33) | (2.09) | — | — | (16.82) |
EV/FCF |
— | — | — | — | — | (7.28) | (2.07) | — | — | (16.72) |
Quick Ratio |
16.14 | 17.20 | 19.17 | 5.70 | 2.70 | 3.37 | 10.22 | 6.61 | 11.74 | 10.22 |
Current Ratio |
16.40 | 17.39 | 19.42 | 5.92 | 2.95 | 4.30 | 10.39 | 6.76 | 11.88 | 10.53 |
Net Debt/EBITDA |
1.86 | 1.54 | 1.62 | 0.39 | 0.19 | 0.28 | (0.08) | 1.05 | 2.14 | 1.06 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 16.03% | 27.50% | 20.74% | 84.64% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.22 | 0.50 | 0.32 | (29.32) | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.85 | 0.43 | 0.64 | 0.73 | 0.71 | 0.85 | 0.80 | 0.78 | 0.68 | 0.74 |
Capex/Depreciation |
(0.08) | (2.48) | (0.24) | (0.95) | (0.40) | (0.38) | (0.30) | (0.10) | (0.11) | (0.31) |
| (48.86%) | (71.72%) | (66.85%) | (96.78%) | (185.90%) | (217.33%) | (349.89%) | (200.47%) | (67.31%) | (74.45%) | |
| (46.84%) | (67.16%) | (62.34%) | (83.46%) | (119.82%) | (133.26%) | (88.56%) | (61.61%) | (55.93%) | (64.12%) | |
ROIC |
(67.29%) | (203.55%) | (351.46%) | (248.56%) | (226.70%) | (214.91%) | (1,434.21%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(59.62%) | (65.83%) | (63.18%) | (191.64%) | (289.29%) | (208.22%) | (100.65%) | (105.14%) | (48.47%) | (95.08%) |
Average Days of Receivables |
— | — | — | — | — | 15.70 | 0.00 | — | — | 285.74 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2,019.75% | 2,977.00% | 0.00% | 0.00% | 12,777.43% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2,385.33% | 3,710.57% | 0.00% | 0.00% | 9,151.14% |
Intangible Assets out of Total Assets |
0.35 | 0.17 | 0.11 | 0.18 | 0.16 | 0.11 | 0.07 | 0.08 | 0.03 | 0.04 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,029.69% | 741.57% | 0.00% | 0.00% | 6,130.57% |
Graham Net Nets |
— | — | — | — | — | 0.04 | (0.19) | — | — | 0.08 |
Graham Number |
— | — | — | — | — | 0.00 | 1.62 | — | — | 0.00 |
Earnings Yield |
— | — | — | — | — | (15.46%) | (64.00%) | — | — | (7.87%) |
Free Cash Flow Yield |
— | — | — | — | — | (13.17%) | (50.81%) | — | — | (5.88%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.02 | 0.00 | 0.00 | 0.01 |
Operating CF per Share |
(0.73) | (0.75) | (1.40) | (1.65) | (1.52) | (1.93) | (1.39) | (0.66) | (0.62) | (0.80) |
Capex per Share |
(0.01) | (0.17) | (0.02) | (0.03) | (0.02) | (0.02) | (0.01) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.74) | (0.92) | (1.42) | (1.68) | (1.54) | (1.95) | (1.40) | (0.67) | (0.62) | (0.81) |
Cash per Share |
1.49 | 2.58 | 3.49 | 1.22 | 0.88 | 1.02 | 1.80 | 0.89 | 2.02 | 1.20 |
Shareholders Equity per Share |
2.30 | 3.12 | 3.88 | 1.48 | 0.98 | 1.28 | (0.07) | 0.89 | 1.97 | 1.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.30 | 3.12 | 3.88 | 1.48 | 0.98 | 1.28 | (0.07) | 0.89 | 1.97 | 1.20 |
Free Cash Flow |
(8.11) | (13.64) | (24.17) | (34.79) | (35.81) | (54.53) | (47.41) | (33.16) | (36.47) | (54.46) |
Working Capital |
15.65 | 36.27 | 57.25 | 21.94 | 14.75 | 28.11 | 56.17 | 38.62 | 109.39 | 75.50 |
Capital Expenditures |
(0.06) | (2.55) | (0.28) | (0.61) | (0.44) | (0.44) | (0.40) | (0.12) | (0.12) | (0.33) |
Net Current Asset Value |
15.65 | 34.66 | 56.06 | 15.23 | 3.94 | 18.07 | (17.98) | 30.53 | 101.85 | 69.54 |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.57 | 0.00 | 0.00 | 0.96 |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.41 | 0.40 | 0.54 | 0.25 | 0.44 | 0.47 | 0.69 | 0.79 | 1.02 | 1.02 |
Cash ROIC |
(19.46%) | (16.22%) | (19.20%) | (55.36%) | (65.43%) | (72.18%) | (37.99%) | (37.38%) | (15.66%) | (33.74%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 0.00 | — | — | 2.09 |
Accounts Payable Turnover |
2.88 | 1.91 | 1.28 | 0.72 | 0.60 | 0.85 | 5.34 | 0.00 | 0.00 | 0.24 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.18 |
Average Days of Payables |
127.44 | 285.14 | 354.41 | 617.67 | 572.33 | 538.60 | 48.07 | 0.00 | 0.00 | 1,880.53 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,080.16 | 0.00 | — | — | 92.10 |
Average Receivables |
— | — | — | — | — | — | — | — | — | 0.17 |
Average Payables |
0.26 | 0.52 | 1.03 | 1.62 | 1.84 | 2.31 | 2.24 | 1.70 | 1.75 | 2.23 |
Average Inventory |
— | — | — | — | — | — | — | — | — | 2.98 |
Average Assets |
20.32 | 38.07 | 60.23 | 56.28 | 41.60 | 47.77 | 66.06 | 68.52 | 95.81 | 113.50 |
Average Common Equity |
19.48 | 35.65 | 56.16 | 48.54 | 26.82 | 29.29 | 16.72 | 21.06 | 79.61 | 97.76 |
Columns are period end dates